Split History
ETFs Holding LRMR »    LRMR Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for patients suffering from rare diseases using its cell penetrating peptide technology platform. Co.'s lead product candidate, CTI-1601, is a biologic fusion protein that is administered subcutaneously, consists of a cell penetrating peptide (CPP) genetically fused to human frataxin (FXN), and includes a mitochondrial targeting sequence. Using its proprietary peptide delivery technology, CTI-1601 carries the molecule from the intravascular space across the cell membrane and into the mitochondria where the CPP and the mitochondrial targeting sequence are cleaved off to yield mature FXN. According to our LRMR split history records, Larimar Therapeutics has had 1 split.
LRMR split history picture
Larimar Therapeutics (LRMR) has 1 split in our LRMR split history database. The split for LRMR took place on May 29, 2020. This was a 1 for 12 reverse split, meaning for each 12 shares of LRMR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.

When a company such as Larimar Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the LRMR split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Larimar Therapeutics shares, starting with a $10,000 purchase of LRMR, presented on a split-history-adjusted basis factoring in the complete LRMR split history. LRMR split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/20/2014
End date: 04/25/2024
Start price/share: $237.60
End price/share: $6.33
Dividends collected/share: $0.00
Total return: -97.34%
Average Annual Total Return: -30.78%
Starting investment: $10,000.00
Ending investment: $266.39
Years: 9.85
Date Ratio
05/29/20201 for 12
LRMR is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

LSTA Split History
LUX Split History
LXRX Split History
MACK Split History
MBIO Split History
MBOT Split History
MBRX Split History
MBVX Split History
MCK Split History
MD Split History

Also explore: LRMR shares outstanding history

Email EnvelopeFree LRMR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Recon Technology, Ltd. (RCON)
iSun, Inc. (ISUN)
Avenue Therapeutics, Inc. (ATXI)
Bakkt Holdings, Inc. (BKKT)
Applied DNA Sciences, Inc. (APDN)
Cidara Therapeutics, Inc. (CDTX)
Smart for Life, Inc. (SMFL)
Windtree Therapeutics, Inc. (WINT)
Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

LRMR Insider Buying

LRMR Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.